Last reviewed · How we verify

NCT02825667

Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of Ankle

Completed NA Last updated 28 September 2017
What this trial tests

NA trial testing Physiotherapy sessions in Haemophilia in 65 participants. Completed in 26 September 2017.

Timeline
12 September 2016
Primary endpoint
8 September 2017
26 September 2017

Quick facts

Lead sponsorReal Fundación Victoria Eugenia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment65
Start date12 September 2016
Primary completion8 September 2017
Estimated completion26 September 2017

Drugs / interventions tested

Conditions studied

Sponsor

Real Fundación Victoria Eugenia

Who can join

18 and older, male only, with Haemophilia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized clinical trial to assess the efficacy of a treatment protocol applied fascial therapy in patients with hemophilic arthropathy ankle, oriented to know and describe the observed differences on the dependent variables: range of motion, pain and physical condition. At the same time, the study will determine whether there are adverse effects or bleeding complications as a result of applied physiotherapy treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Real Fundación Victoria Eugenia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02825667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing